UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 1, 2013

Accession Number:	0001144204-13-016755
Submission Type:	POS AM
CIK: 0001541157 Company Name: Morria Biopharmaceuticals PLC File Number: 333-185247